BRK-B vs GCMG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GCMG presents a complex profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between its Graham Number ($2.05) and Intrinsic Value ($12.39). While the company exhibits explosive earnings growth (104.4% YoY) and an attractive forward P/E of 9.22, these strengths are offset by a critical dividend payout ratio of 107.14%, indicating an unsustainable yield. Technicals are currently heavily bearish (0/100), suggesting the market is discounting the strong earnings surprises in favor of broader sector headwinds or balance sheet concerns.
Compare Another Pair
Related Comparisons
BRK-B vs GCMG: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and GCM Grosvenor Inc. (GCMG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.